Low High Density Lipoprotein Cholesterol: Prevalence and Associated Risk-Factors in a Large French Population

Annals of Epidemiology

Volumn 21, Issue 2, 2011, Pages 118-127

  Rouvre, Marion ^a   Vol, Sylviane ^b   Gusto, Gaelle ^b   Born, Catherine ^b   Lantieri, Olivier ^b   Tichet, Jean ^b   Lecomte, Pierre ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b Institut Inter Regional Pour la Sante   (France)

Author keywords

Epidemiologic study; HDL cholesterol; Psychosocial deprivation; Reference values; Risk factors; Risk reduction behavior

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; HYPERTRIGLYCERIDEMIA; LEUKOCYTOSIS; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SEDENTARY LIFESTYLE; SEX RATIO; SMOKING; SOCIAL ISOLATION;

ABDOMINAL FAT; ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; FEMALE; FRANCE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; SOCIAL CLASS; YOUNG ADULT;

EID: 78650370329     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.07.097     Document Type: Article

References (57)

1. Assmann G., Schulte H., von Eckardstein A., Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996, 124(Suppl):S11-S20.
2. Despres J.P., Lemieux I., Dagenais G.R., Cantin B., Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 2000, 153:263-272.
3. Briel M., Ferreira-Gonzalez I., You J.J., Karanicolas P.J., Akl E.A., Wu P., et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ 2009, 338:b92.
4. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
5. Barter P., Gotto A.M., Larosa J.C., Maroni J., Szarek M., Grundy S.M., et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007, 357:1301-1310.
6. Connelly P.W., Petrasovits A., Stachenko S., MacLean D.R., Little J.A., Chockalingam A. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999, 15:428-433.
7. Tall A.R. Plasma high density lipoprotein. Metabolism and relationship to atherosclerosis. J Clin Invest 1990, 86:379-384.
8. Couillard C., Després J.P., Lamarche B., Bergeron J., Gagnon J., Leon A.S., et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the health risk factors, exercise training and genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2001, 21:1226-1232.
9. Slentz C.A., Houmard J.A., Johnson J.L., Bateman L.A., Tanner C.J., McCartney J.S., et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol 2007, 103:432-442.
10. Seip R.L., Moulin P., Cocke T., Tall A., Kohrt W.M., Mankowitz K., et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb 1993, 13:1359-1367.
11. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. American Heart Association. National Heart, Lung, and Blood Institute.
12. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
13. Pannier B., Thomas F., Eschwège E., Bean K., Benetos A., Leocmach Y., et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the " SYMFONIE" study. Diabetes Metab 2006, 32:467-474.
14. Ghandehari H., Kamal-Bahl S., Wong N.D. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 2008, 156:112-119.
15. Kim S.M., Han J.H., Park H.S. Prevalence of low HDL-Cholesterol levels and associated factors among Koreans. Circ J 2006, 70:820-826.
16. Morales D.D., Punzalan F.E., Paz-Pacheco E., Sy R.G., Duante C.A. National Nutrition And Health Survey: 2003 Group. Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus. Diab Vasc Dis Res 2008, 5:36-43.
17. Ford E.S., Giles W.H., Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004, 27:2444-2449.
18. Sass C, Dupré C, Dauphinot V, Labbe E, Guéguen R, Gerbaud L, et al. The EPICES score: an individual index of material and social deprivation related to health status. Part 2: evaluation in a population of 197,389 subjects [article online], 2005. Available at: Accessed January 2005. http://www.cetaf.asso.fr/protocoles/precarite/protocoles_epices.htm#publis.
19. Inégalités de niveau de vie et mesures de la pauvreté en 2006. Les revenus et le patrimoine des ménages [article online], 2009. Available at: Accessed 16 January 2010. http://www.insee.fr/fr/ffc/docs_ffc/ref/revpmen09b.PDF.
20. Lasfargues G., Vol S., Le Clésiau H., Bedouet M., Hagel L., Constans T., et al. Validity of a short self-administered dietary questionnaire compared with a dietetic interview. Presse Med 1990, 19:953-957.
21. Bedogni G., Bellentani S., Miglioli L., Masutti F., Passalacqua M., Castiglione A., et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006, 2:6-33.
22. Ferrara A., Barrett-Connor E., Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 1997, 96:37-43.
23. Berg C.M., Lissner L., Aires N., Lappas G., Torén K., Wilhelmsen L., et al. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil 2005, 12:115-125.
24. Freedman D.S., Otvos J.D., Jeyarajah E.J., Shalaurova I., Cupples L.A., Parise H., et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 2004, 50:1189-1200.
25. Kim C.J., Kim T.H., Ryu W.S., Ryoo U.H. Influence of menopause on high density lipoprotein-cholesterol and lipids. J Korean Med Sci 2000, 15:380-386.
26. Kromhout D., Nissinen A., Menotti A., Bloemberg B., Pekkanen J., Giampaoli S. Total and HDL cholesterol and their correlates in elderly men in Finland, Italy, and The Netherlands. Am J Epidemiol 1990, 131:855-863.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
28. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. World Health Organization.
29. Langlois M.R., Blaton V.H. Historical milestones in measurement of HDL-cholesterol: impact on clinical and laboratory practice. Clin Chim Acta 2006, 369:168-178.
30. Linn S., Fulwood R., Carroll M., Brook J.G., Johnson C., Kalsbeek W.D., Rifkind B.M. Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (NHANES II). Am J Public Health 1991, 81:1038-1043.
31. Muntner P., He J., Chen J., Fonseca V., Whelton P.K. Prevalence of nontraditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 2004, 14:686-695.
32. Tian J.Y., Yang Y., Cheng Q., Huang H.E., Li R., Jiang G.X., et al. Association of WBC count and glucose metabolism among Chinese population aged 40 years and over. Diabetes Res Clin Pract 2008, 82:132-138.
33. Kotronen A., Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
34. Angeli F., Reboldi G., Gentile G., Verdecchia P. The emerging role of high-density lipoprotein cholesterol in hypertension trials. J Hypertens 2009, 27:458-460.
35. Jackson R., Stewart A., Beaglehole R., Scragg R. Alcohol consumption and blood pressure. Am J Epidemiol 1985, 122:1037-1044.
36. Kapur N.K., Ashen D., Blumenthal R.S. High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Vasc Health Risk Manag 2008, 4:39-57.
37. Terán-García M., Després J.P., Couillard C., Tremblay A., Bouchard C. Effects of long-term overfeeding on plasma lipoprotein levels in identical twins. Atherosclerosis 2004, 173:277-283.
38. Lichtenstein A.H., Ausman L.M., Jalbert S.M., Schaefer E.J. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 1999, 340:1933-1940.
39. Mukamal K.J., Mackey R.H., Kuller L.H., Tracy R.P., Kronmal R.A., Mittleman M.A., et al. Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab 2007, 92:2559-2566.
40. Castelli W.P., Doyle J.T., Gordon T., Hames C.G., Hjortland M.C., Hulley S.B., et al. Alcohol and blood lipids. The Cooperative Lipoprotein Phenotyping Study. Lancet 1977, 2:153-155.
41. Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999, 319:1523-1528.
42. Mooradian A.D., Haas M.J., Wong N.C. The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels. Endocr Rev 2006, 27:2-16.
43. Sacks F.M., Bray G.A., Carey V.J., Smith S.R., Ryan D.H., Anton S.D., et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009, 360:859-873.
44. Ma Y., Li Y., Chiriboga D.E., Olendzki B.C., Hebert J.R., Li W., et al. Association between carbohydrate intake and serum lipids. J Am Coll Nutr 2006, 25:155-163.
45. Drouillet P., Balkau B., Charles M.A., Vol S., Bedouet M., Ducimetière P. Calcium consumption and insulin resistance syndrome parameters. Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Nutr Metab Cardiovasc Dis 2007, 17:486-492. The Desir Study Group.
46. Major G.C., Alarie F., Doré J., Phouttama S., Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007, 85:54-59.
47. Reid I.R., Mason B., Horne A., Ames R., Clearwater J., Bava U., et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 2002, 112:343-347.
48. Reid I.R., Ames R., Mason B., Bolland M.J., Bacon C.J., Reid H.E., et al. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr 2010, 91:131-139.
49. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 2000, 14:1132-1138.
50. Moffatt R.J. Effects of cessation of smoking on serum lipids and high density lipoprotein-cholesterol. Atherosclerosis 1988, 74:85-89.
51. Maeda K., Noguchi Y., Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 2003, 37:283-290.
52. Craig W.Y., Palomaki G.E., Haddow J.E. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989, 298:784-788.
53. Hausenloy D.J., Yellon D.M. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart 2008, 94:706-714.
54. Perova N.V., Davis C.E., Tao S., Pajak A., Stein Y., Broda G.B., et al. Multi-country comparison of plasma lipid relationship to years of schooling in men and women. Int J Epidemiol 2001, 30:371-379.
55. La Rosa E., Le Clésiau H., Valensi P. Metabolic syndrome and psychosocial deprivation. Data collected from a Paris suburb. Diabetes Metab 2008, 34:155-161.
56. Myllykangas M., Pekkanen J., Rasi V., Haukkala A., Vahtera E., Salomaa V. Haemostatic and other cardiovascular risk factors, and socioeconomic status among middle-aged Finnish men and women. Int J Epidemiol 1995, 24:1110-1116.
57. Wamala S., Merlo J., Boström G., Hogstedt C. Perceived discrimination, socioeconomic disadvantage and refraining from seeking medical treatment in Sweden. J Epidemiol Community Health 2007, 61:409-415.